Introduced Version
HOUSE BILL No. 1188
_____
DIGEST OF INTRODUCED BILL
Citations Affected: IC 12-15-5-13.
Synopsis: Mental health and addiction services. Prohibits lifetime
limitations on a Medicaid recipient receiving substance use disorder
inpatient rehabilitation or treatment.
Effective: July 1, 2024.
Pack
January 9, 2024, read first time and referred to Committee on Public Health.
2024 IN 1188—LS 6632/DI 104 Introduced
Second Regular Session of the 123rd General Assembly (2024)
PRINTING CODE. Amendments: Whenever an existing statute (or a section of the Indiana
Constitution) is being amended, the text of the existing provision will appear in this style type,
additions will appear in this style type, and deletions will appear in this style type.
Additions: Whenever a new statutory provision is being enacted (or a new constitutional
provision adopted), the text of the new provision will appear in this style type. Also, the
word NEW will appear in that style type in the introductory clause of each SECTION that adds
a new provision to the Indiana Code or the Indiana Constitution.
Conflict reconciliation: Text in a statute in this style type or this style type reconciles conflicts
between statutes enacted by the 2023 Regular Session of the General Assembly.
HOUSE BILL No. 1188
A BILL FOR AN ACT to amend the Indiana Code concerning
human services.
Be it enacted by the General Assembly of the State of Indiana:
1 SECTION 1. IC 12-15-5-13, AS AMENDED BY P.L.179-2019,
2 SECTION 1, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
3 JULY 1, 2024]: Sec. 13. (a) The office shall provide coverage for
4 treatment of opioid or alcohol dependence that includes the following:
5 (1) Counseling services that address the psychological and
6 behavioral aspects of addiction.
7 (2) When medically indicated, drug treatment involving agents
8 approved by the federal Food and Drug Administration for the:
9 (A) treatment of opioid or alcohol dependence; or
10 (B) prevention of relapse to opioids or alcohol after
11 detoxification.
12 (3) When determined by the treatment plan to be medically
13 necessary, inpatient detoxification in accordance with the most
14 current edition of the American Society of Addiction Medicine
15 Patient Placement Criteria.
16 (b) The office shall:
17 (1) develop quality measures to ensure; and
2024 IN 1188—LS 6632/DI 104 2
1 (2) require a managed care organization to report;
2 compliance with the coverage required under subsection (a).
3 (c) The office may implement quality capitation withholding of
4 reimbursement to ensure that a managed care organization has
5 provided the coverage required under subsection (a).
6 (d) The office shall report the clinical use of the medications
7 covered under this section to the mental health Medicaid quality
8 advisory committee established by IC 12-15-35-51. The mental health
9 Medicaid quality advisory committee may make recommendations to
10 the office concerning this section.
11 (e) The office may not place an overall limitation on the amount
12 of substance use disorder inpatient rehabilitation or treatment that
13 a Medicaid recipient may receive in the recipient's lifetime.
2024 IN 1188—LS 6632/DI 104